These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9038613

  • 1. Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria.
    Kerbl R, Urban CE, Ambros PF, Lackner H, Ladenstein R, Spuller E, Mutz I, Ambros I, Amann G, Gadner H, Parker L.
    Eur J Cancer; 1996 Dec; 32A(13):2298-305. PubMed ID: 9038613
    [Abstract] [Full Text] [Related]

  • 2. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
    Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, Esteve J, Thiesse P, Combaret V, Chauvot P, Boschetti R, David L, Brunat-Mentigny M, Philip T.
    Med Pediatr Oncol; 1997 Feb; 28(2):81-91. PubMed ID: 8986143
    [Abstract] [Full Text] [Related]

  • 3. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
    Kerbl R, Urban CE, Ladenstein R, Ambros IM, Spuller E, Mutz I, Amann G, Kovar H, Gadner H, Ambros PF.
    Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
    [Abstract] [Full Text] [Related]

  • 4. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F, Baillot A, Hero B, Schurr P, Nerenz A, Hunneman DH, Sander J.
    J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
    [Abstract] [Full Text] [Related]

  • 5. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
    Kerbl R, Urban CE, Ladenstein R, Schnellauf C, Sitzwohl C, Lackner H, Gleispach H, Fauler G, Ambros PF, Ambros IM, Rumpler S, Gadner H, Spuller E, Höfler G, Amann G, Kytir J, Mutz I.
    Wien Klin Wochenschr; 1996 Apr; 108(13):398-403. PubMed ID: 8766424
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
    Mathieu P, Frappaz D, Chauvin F, Combaret V, Vercherat M, Brunat-Mentigny M, David L, Esteve J, Favrot M, Fouillat V, Greffe J, Lasset C, Renaud P, Philip T.
    Early Hum Dev; 1996 Sep 20; 46(1-2):177-96. PubMed ID: 9019414
    [Abstract] [Full Text] [Related]

  • 8. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
    Yokomori K, Hori T, Tsuchida Y, Kuroda M, Yoshioka M.
    J Pediatr Surg; 1989 Apr 20; 24(4):391-4. PubMed ID: 2659761
    [Abstract] [Full Text] [Related]

  • 9. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
    Kerbl R, Urban CE, Ambros IM, Dornbusch HJ, Schwinger W, Lackner H, Ladenstein R, Strenger V, Gadner H, Ambros PF.
    J Clin Oncol; 2003 Nov 15; 21(22):4228-34. PubMed ID: 14615452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 15; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA, Hachitanda Y, Woods WG, Tuchman M, Lemieux B, Brisson L, Bernstein M, Brossard J, Leclerc JM, Byrne TD.
    Cancer; 1995 Dec 01; 76(11):2363-71. PubMed ID: 8635044
    [Abstract] [Full Text] [Related]

  • 16. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG.
    Pediatrics; 1990 Nov 01; 86(5):765-73. PubMed ID: 2152340
    [Abstract] [Full Text] [Related]

  • 17. Screening for neuroblastoma in the north of England.
    Parker L, Craft AW, Dale G, Bell S, Cole M, McGill AC, Seviour JA, Smith J.
    BMJ; 1992 Nov 21; 305(6864):1260-3. PubMed ID: 1303649
    [Abstract] [Full Text] [Related]

  • 18. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y, Ohi R, Yaoita S, Nakamura M, Kikuchi Y, Konno T, Tsuchiya S, Shiraishi H.
    J Pediatr Surg; 1995 Mar 21; 30(3):467-70. PubMed ID: 7760244
    [Abstract] [Full Text] [Related]

  • 19. Mass screening of neuroblastoma in infancy.
    Sawada T, Todo S, Fujita K, Iino S, Imashuku S, Kusunoki T.
    Am J Dis Child; 1982 Aug 21; 136(8):710-2. PubMed ID: 6808827
    [Abstract] [Full Text] [Related]

  • 20. Neuroblastoma screening: labeling of HVA and VMA for stable isotope dilution gas chromatography-mass spectrometry.
    Gleispach H, Huber E, Fauler G, Kerbl R, Urban C, Leis HJ.
    Nutrition; 1995 Aug 21; 11(5 Suppl):604-6. PubMed ID: 8748233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.